RONALD ORDAS: Open Payments
NPI 1932450426 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,349 in 71 payments from 20 companies in 2025. Trend: 2023 $2,093 · 2024 $1,745 · 2025 $2,349
Food & beverage: $2,349
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $337 |
| AstraZeneca Pharmaceuticals LP | 5 | $332 |
| Novartis Pharmaceuticals Corporation | 14 | $300 |
| E.R. Squibb & Sons, L.L.C. | 9 | $283 |
| Boston Scientific Corporation | 3 | $180 |
| Esperion Therapeutics, Inc. | 1 | $112 |
| PFIZER INC. | 6 | $104 |
| Alnylam Pharmaceuticals Inc. | 4 | $86 |
| Novo Nordisk Inc | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $80 |
Products named: LEQVIO, LOKELMA, CAMZYOS, SAPIEN 3 Ultra RESILIA, WATCHMAN FLX, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, NEXLETOL, ELIQUIS.
Industry payments across AZ — which companies pay providers there.
